The Cost of Free: What Removing FDA User Fees Could Mean for Drug Innovation and Public Health

In the ongoing debate over regulatory reform, the MAHA Commission’s proposal to eliminate FDA user fees has sparked renewed scrutiny of the relationship between industry and government. At first glance, removing these fees may seem like a step toward reducing corporate influence and restoring scientific integrity….
By: Womble Bond Dickinson